Open main menu
Search Ctrl + K
Sign up for free
Loading...
Talaris Therapeutics, Inc.
Watch
Biological Products, (no Diagnostic Substances)
NASDAQ.TALS
570 Preston St., Suite 400, Louisville, KY, 40202
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
News
8-K
Regulation Fd Disclosure, Financial Statements And Exhibits
05 Sep 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
08 Aug 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers
27 Jun 24
8-K
Submission Of Matters To A Vote Of Security Holders
07 Jun 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
13 May 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
19 Mar 24
8-K
Other Events, Financial Statements And Exhibits
14 Nov 23
Proxies
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
19 Apr 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
19 Apr 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
28 Apr 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
28 Apr 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
29 Apr 22
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
29 Apr 22
Financials
10-Q
Quarterly Filing
08 Aug 24
10-Q
Quarterly Filing
13 May 24
10-K
Fiscal Year 2023
19 Mar 24
10-Q
Quarterly Filing
14 Nov 23
10-Q
Quarterly Filing
14 Aug 23
10-Q
Quarterly Filing
15 May 23
10-K
Fiscal Year 2022
31 Mar 23
Prospectuses and Registrations
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
19 Mar 24
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
26 Jan 24
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
25 Jan 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
23 Oct 23
424B3
Prospectus Filed Pursuant To Rule 424(b)(3).
15 Sep 23
S-4/A
Amendment To The S-4 Registration Statement.
13 Sep 23
S-4/A
Amendment To The S-4 Registration Statement.
11 Sep 23
Other
ARS
Scanned Paper Annual Report Submission.
19 Apr 24
425
Filed In Connection With Business Combination Subject To Rule 425.
10 Oct 23
425
Filed In Connection With Business Combination Subject To Rule 425.
10 Oct 23
425
Filed In Connection With Business Combination Subject To Rule 425.
06 Oct 23
425
Filed In Connection With Business Combination Subject To Rule 425.
26 Sep 23
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
14 Sep 23
SEC STAFF LETTER
Correspondence Between The Sec's Staff And Filers.
14 Sep 23
Ownership
4
Kulkarni Sandeep Chidambar
22 Aug 24
4
Kulkarni Sandeep Chidambar
20 Aug 24
4
Robinson Ryan F.
27 Jun 24
4
Castelein Caley
07 Jun 24
4
Siegall Clay B
07 Jun 24
4
Srivastava Sapna
07 Jun 24
4
Thiara Parvinder
07 Jun 24